Table 1 Comparison of DHEAS (top) and age (bottom) in COVID-19 patients, healthy participants (control), and different groups of patients.
N | Mean ± SD | Median | Q1 | Q3 | p.value1 | p.value2 | |||
|---|---|---|---|---|---|---|---|---|---|
DHEAS (µg/dL) | Groups | patients | 694 | 100.18 ± 87.57 | 78.25 | 35.80 | 137.00 | ||
Control | 211 | 127.00 ± 98.96 | 99.60 | 52.40 | 186.00 | < 0.001 | |||
Groups | Inpatient | 388 | 83.50 ± 79.73 | 57.50 | 27.05 | 110.00 | < 0.001 | ||
Outpatient | 306 | 121.35 ± 92.49 | 104.00 | 53.80 | 165.00 | < 0.001 | 0.757 | ||
Control | 211 | 127.00 ± 98.96 | 99.60 | 52.40 | 186.00 | ||||
Inpatient | No ICU Care | 350 | 82.18 ± 79.25 | 57.15 | 27.00 | 107.00 | |||
ICU Care | 38 | 95.64 ± 84.18 | 77.65 | 28.70 | 137.00 | 0.323 | |||
Expire | 35 | 83.08 ± 81.72 | 56.40 | 23.70 | 127.00 | ||||
Alive | 353 | 83.54 ± 79.65 | 57.60 | 28.70 | 108.00 | 0.974 | |||
Age (years) | Groups | patients | 686 | 50.72 ± 16.35 | 50.00 | 38.00 | 61.00 | ||
Control | 209 | 46.68 ± 13.49 | 36.00 | 36.00 | 57.00 | 0.001 | |||
Groups | Inpatient | 384 | 56.00 ± 16.00 | 55.00 | 44.00 | 68.00 | < 0.001 | ||
Outpatient | 302 | 44.00 ± 14.00 | 43.00 | 33.00 | 54.00 | < 0.001 | 0.080 | ||
Control | 209 | 47.00 ± 13.00 | 50.00 | 36.00 | 57.00 | ||||
Inpatient | No ICU Care | 346 | 55.20 ± 16.06 | 54.00 | 44.00 | 67.00 | |||
ICU Care | 38 | 59.53 ± 18.08 | 62.00 | 49.00 | 72.00 | 0.121 | |||
Expire | 34 | 67.21 ± 15.13 | 68.0 | 52.00 | 78.00 | ||||
Alive | 350 | 54.51 ± 15.98 | 54.60 | 43.00 | 67.00 | < 0.001 | |||
